BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1988309)

  • 1. The expression of 22-kD subunit of cytochrome b558 in patients with X-linked chronic granulomatous disease.
    Tomizawa K; Sakiyama Y; Matsumoto S; Nakamura M
    Eur J Haematol; 1991 Jan; 46(1):52-4. PubMed ID: 1988309
    [No Abstract]   [Full Text] [Related]  

  • 2. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558.
    Tsunawaki S; Mizunari H; Namiki H; Kuratsuji T
    J Exp Med; 1994 Jan; 179(1):291-7. PubMed ID: 8270871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease.
    Tsuda M; Kaneda M; Sakiyama T; Inana I; Owada M; Kiryu C; Shiraishi T; Kakinuma K
    Hum Genet; 1998 Oct; 103(4):377-81. PubMed ID: 9856476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular and cellular pathology of chronic granulomatous disease.
    Segal AW
    Eur J Clin Invest; 1988 Oct; 18(5):433-43. PubMed ID: 2852593
    [No Abstract]   [Full Text] [Related]  

  • 5. Two novel point mutations in the cytochrome b 558 heavy chain gene, detected in two Japanese patients with X-linked chronic granulomatous disease.
    Ariga T; Sakiyama Y; Matsumoto S
    Hum Genet; 1994 Oct; 94(4):441. PubMed ID: 7927345
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.
    Porter CD; Kuribayashi F; Parkar MH; Roos D; Kinnon C
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):571-5. PubMed ID: 8615831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant X-linked chronic granulomatous disease patient (X91+) with partially functional cytochrome b.
    Cross AR; Heyworth PG; Rae J; Curnutte JT
    J Biol Chem; 1995 Apr; 270(14):8194-200. PubMed ID: 7713925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: variants of the X-linked, cytochrome b558-negative form of the disease.
    Roos D; de Boer M; Borregard N; Bjerrum OW; Valerius NH; Seger RA; Mühlebach T; Belohradsky BH; Weening RS
    J Leukoc Biol; 1992 Feb; 51(2):164-71. PubMed ID: 1431553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulomatous disease: mutations in cytochrome b558.
    Roos D; De Boer M; De Klein A; Bolscher BG; Weening RS
    Immunodeficiency; 1993; 4(1-4):289-301. PubMed ID: 8167720
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered expression of neutrophil peripheral benzodiazepine receptor in X-linked chronic granulomatous disease.
    Zavala F; Veber F; Descamps-Latscha B
    Blood; 1990 Jul; 76(1):184-8. PubMed ID: 2163694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncommon missense and splice mutations and resulting biochemical phenotypes in German patients with X-linked chronic granulomatous disease.
    Roesler J; Heyden S; Burdelski M; Schäfer H; Kreth HW; Lehmann R; Paul D; Marzahn J; Gahr M; Rösen-Wolff A
    Exp Hematol; 1999 Mar; 27(3):505-11. PubMed ID: 10089913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease.
    Ariga T; Sakiyama Y; Tomizawa K; Imajoh-Ohmi S; Kanegasaki S; Matsumoto S
    Eur J Pediatr; 1993 Jun; 152(6):469-72. PubMed ID: 8101486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic granulomatous disease.
    Segal AW
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():195-8. PubMed ID: 2032145
    [No Abstract]   [Full Text] [Related]  

  • 14. Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease.
    Bolscher BG; de Boer M; de Klein A; Weening RS; Roos D
    Blood; 1991 Jun; 77(11):2482-7. PubMed ID: 1710153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic granulomatous disease.
    Curnutte JT; Babior BM
    Adv Hum Genet; 1987; 16():229-97. PubMed ID: 3031956
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical X-linked variant of chronic granulomatous disease.
    Wilson AG; Munro DD; Walker-Smith JA
    J R Soc Med; 1990 Dec; 83(12):801-2. PubMed ID: 2269970
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematologically important mutations: X-linked chronic granulomatous disease--an update.
    Heyworth PG; Curnutte JT; Noack D; Cross AR
    Blood Cells Mol Dis; 1997 Dec; 23(3):443-50. PubMed ID: 9454688
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of oxygen radicals by fibroblasts and neutrophils from a patient with x-linked chronic granulomatous disease.
    Emmendörffer A; Roesler J; Elsner J; Raeder E; Lohmann-Matthes ML; Meier B
    Eur J Haematol; 1993 Oct; 51(4):223-7. PubMed ID: 8243611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome b positive X-linked chronic granulomatous disease: a normal cell surface expression of cytochrome b.
    Azuma H; Oomi H; Ueda D; Sasaki K; Makita Y; Tomizawa K; Sakiyama Y; Fujita K; Yoshioka H; Okuno A
    Eur J Pediatr; 1992 Apr; 151(4):279-82. PubMed ID: 1323464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils.
    Verhoeven AJ; Bolscher BG; Meerhof LJ; van Zwieten R; Keijer J; Weening RS; Roos D
    Blood; 1989 May; 73(6):1686-94. PubMed ID: 2469497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.